Global Anticancer Drugs Market by Drug Type, Cancer Type, Therapy and Region - Forecast to 2023: An $139.4 Billion Opportunity - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 1, 2018--The “Global Anticancer Drugs Market - by Drug Type, Cancer Type, Therapy, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)” report has been added to ResearchAndMarkets.com’s offering.
The global anticancer drugs market was 94.5 billion USD in 2017 and will reach 139.4 billion USD by 2023 with a CAGR of 6.69% during the period.
The growing awareness towards cancer diagnosis and treatment, and increasing research and development activities drive the growth of the market. However, high cost of treatment may hinder the growth of the market.
The U.S., U.K. and Germany are leading the market due to developed healthcare infrastructure and government initiatives to increase public awareness. Asia-Pacific will show significant growth rate owing to increase in cancer incidences and growing population in certain economies like India, China, Japan and South Korea.
Industry Trends & UpdatesEli Lilly acquired California-based ARMO BioScience and Montreal-based AurKa Pharma Inc. Israeli scientists invented system to deliver cancer drugs to children using nanotechnology.
Companies ProfiledCelgene Pfizer Novartis Eli Lilly Bayer Takeda Amgen GlaxoSmithKline Bristol-Myers Roche Holding Johnson & Johnson Gilead Otsuka Teva ARIAD
Key Topics Covered
1. Research Methodology
2. Executive Summary
3. Market Overview
4. Market Dynamics
5. Global Anticancer Drugs Market Segmentation, Forecasts and Trends - by Drug Type
6. Global Anticancer Drugs Market Segmentation, Forecasts and Trends - by Cancer Type
7. Global Anticancer Drugs Market Segmentation, Forecasts and Trends - by Therapy
8. Global Anticancer Drugs Market Segmentation, Forecasts and Trends - by Region
9. Company Market Share Analysis
10. Company Profiles
11. Industry Structure
12. Global Anticancer Drugs Market - The Road Ahead
For more information about this report visit https://www.researchandmarkets.com/research/mdxzww/global_anticancer?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005762/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Oncology Drugs
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/01/2018 12:06 PM/DISC: 10/01/2018 12:06 PM